Department of Pharmacology, Delhi Institute of Pharmaceutical Sciences & Research, University of Delhi, New Delhi, India.
Microvasc Res. 2013 May;87:65-74. doi: 10.1016/j.mvr.2013.01.002. Epub 2013 Jan 31.
The purpose of the study was to evaluate the effects of hesperetin (Hsp) on diabetes-induced retinal oxidative stress, neuroinflammation and apoptosis in rats. The Hsp treatment (100 mg/kg body weight) was carried for twenty four weeks in STZ-induced diabetic rats and evaluated for antioxidant (Superoxide dismutase; SOD, Catalase; CAT and glutathione; GSH) enzymes, inflammatory cytokines (TNF-α, IL-1β), caspase-3, glial fibrillary acidic protein (GFAP) and aquaporin-4(AQP4) expression. Histological changes were evaluated by light and transmission electron microscopic (LM and TEM) studies. Retinal GSH levels and anti-oxidant enzymes (SOD and CAT) activity were significantly decreased in diabetic group as compared to normal group. However, in Hsp-treated rats, retinal GSH levels were restored close to normal levels and positive modulation of anti-oxidant enzyme activity was observed. Diabetic retinae showed significantly increased expression of Pro-inflammatory cytokines (TNF-α and IL-1β) as compared to normal retinae. While Hsp-treated retinae showed significantly lower levels of cytokines as compared to diabetic retinae. Diabetic retinae showed increased caspase-3, GFAP and AQP4 expression. However, Hsp-treated retinae showed inhibitory effect on caspase-3, GFAP and AQP4 expression. LM images showed edematous Müller cell endfeet, and also degenerated photoreceptor layer; however, protective effect of Hsp was seen on Müller cell processes and photoreceptors. TEM study showed increased basement membrane (BM) thickness in diabetic retina, while relatively thin BM was recorded in Hsp-treated retina. It can be postulated that dietary flavanoids, like Hsp, can be effective for the prevention of diabetes induced neurovascular complications such as diabetic retinopathy.
本研究旨在评估橙皮素(Hsp)对糖尿病大鼠视网膜氧化应激、神经炎症和细胞凋亡的影响。在链脲佐菌素(STZ)诱导的糖尿病大鼠中,Hsp 治疗(100mg/kg 体重)进行了 24 周,并评估了抗氧化(超氧化物歧化酶;SOD、过氧化氢酶;CAT 和谷胱甘肽;GSH)酶、炎性细胞因子(TNF-α、IL-1β)、半胱天冬酶-3、胶质纤维酸性蛋白(GFAP)和水通道蛋白-4(AQP4)的表达。通过光镜和透射电镜(LM 和 TEM)研究评估组织学变化。与正常组相比,糖尿病组视网膜 GSH 水平和抗氧化酶(SOD 和 CAT)活性显著降低。然而,在 Hsp 治疗的大鼠中,视网膜 GSH 水平恢复到接近正常水平,并观察到抗氧化酶活性的正向调节。与正常视网膜相比,糖尿病视网膜显示出明显增加的促炎细胞因子(TNF-α和 IL-1β)的表达。而 Hsp 治疗的视网膜中细胞因子水平明显低于糖尿病视网膜。糖尿病视网膜中 caspase-3、GFAP 和 AQP4 的表达增加。然而,Hsp 治疗的视网膜对 caspase-3、GFAP 和 AQP4 的表达表现出抑制作用。LM 图像显示水肿的 Müller 细胞终足,以及退化的光感受器层;然而,Hsp 对 Müller 细胞突起和光感受器有保护作用。TEM 研究显示糖尿病视网膜的基底膜(BM)厚度增加,而 Hsp 治疗的视网膜中记录到相对较薄的 BM。可以推测,膳食类黄酮,如 Hsp,可能对预防糖尿病引起的神经血管并发症(如糖尿病性视网膜病变)有效。